TIVC
$0.96
Post-MarketAs of Mar 17, 8:00 PM UTC
Tivic Health Systems, Inc.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.96
Potential Upside
5%
Whystock Fair Value$1.01
Price
UndervaluedFair ValueOvervalued
Fundamentals
Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.42M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.01
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-178.18%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
5.44